• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人体内异喹胍的代谢:(1)羟基化的区域选择性以及(2)两名患有卡比马唑诱导的粒细胞缺乏症的同胞患者的异常氧化代谢。

The metabolism of debrisoquine in man: (1) regioselectivity of hydroxylation and (2) aberrant oxidative metabolism in two sibling patients with carbimazole-induced agranulocytosis.

作者信息

Ritchie J C, Crothers M J, Shah R R, Idle J R, Smith R L

出版信息

Xenobiotica. 1986 May;16(5):503-9. doi: 10.3109/00498258609050255.

DOI:10.3109/00498258609050255
PMID:3739370
Abstract

The regioselectivity of the metabolic hydroxylation of debrisoquine has been determined in 43 healthy British white volunteers and the priority was found to be in the order 4 greater than 7 greater than 6 greater than 5 greater than 8. The order of preference for hydroxylation position was independent of debrisoquine 4-hydroxylation phenotype. The extent of total aromatic hydroxylation varied widely between individuals and was largely independent of the extent of 4-hydroxylation, and thus of the influence of the DH/DL locus. Two sisters and their blood relations all excreted comparatively large amounts of the phenolic metabolites in their urine, indicating some genetic basis for the control of aromatic oxidation of debrisoquine in man. These same two sisters had previously developed agranulocytosis in association with carbimazole therapy.

摘要

在43名健康的英国白人志愿者中测定了去甲丙咪嗪代谢性羟基化的区域选择性,发现其优先顺序为4>7>6>5>8。羟基化位置的优先顺序与去甲丙咪嗪4-羟基化表型无关。个体间总的芳香族羟基化程度差异很大,且在很大程度上与4-羟基化程度无关,因此也与DH/DL位点的影响无关。两名姐妹及其血亲的尿液中均排出了相对大量的酚类代谢物,这表明人类体内去甲丙咪嗪芳香族氧化的控制存在某种遗传基础。这两名姐妹此前在接受卡比马唑治疗时曾发生粒细胞缺乏症。

相似文献

1
The metabolism of debrisoquine in man: (1) regioselectivity of hydroxylation and (2) aberrant oxidative metabolism in two sibling patients with carbimazole-induced agranulocytosis.人体内异喹胍的代谢:(1)羟基化的区域选择性以及(2)两名患有卡比马唑诱导的粒细胞缺乏症的同胞患者的异常氧化代谢。
Xenobiotica. 1986 May;16(5):503-9. doi: 10.3109/00498258609050255.
2
Influence of DH/DL alleles regulating debrisoquine oxidation on phenytoin hydroxylation.调控异喹胍氧化的DH/DL等位基因对苯妥英羟化作用的影响。
Clin Pharmacol Ther. 1981 Apr;29(4):493-7. doi: 10.1038/clpt.1981.68.
3
Stereo- and regioselectivity of hepatic oxidation in man--effect of the debrisoquine/sparteine phenotype on bufuralol hydroxylation.人体肝脏氧化的立体选择性和区域选择性——去甲异喹胍/鹰爪豆碱表型对丁呋洛尔羟基化作用的影响
Eur J Clin Pharmacol. 1986;31(3):313-8. doi: 10.1007/BF00981130.
4
Polymorphism of the 4-hydroxylation of debrisoquine in the San Bushmen of southern Africa.
Hum Toxicol. 1988 May;7(3):273-6. doi: 10.1177/096032718800700308.
5
Polymorphism of debrisoquine 4-hydroxylation and family studies of poor metabolizers in Chinese population.中国人中异喹胍4-羟化的多态性及慢代谢者的家系研究。
Zhongguo Yao Li Xue Bao. 1990 Jan;11(1):7-10.
6
Pharmacogenetic covariation of defective N-oxidation of sparteine and 4-hydroxylation of debrisoquine.司巴丁N-氧化缺陷与异喹胍4-羟化的药物遗传学共变。
Eur J Clin Pharmacol. 1980 Feb;17(2):153-5. doi: 10.1007/BF00562624.
7
Animal modelling of human polymorphic drug oxidation--the metabolism of debrisoquine and phenacetin in rat inbred strains.人类多态性药物氧化的动物模型——大鼠近交系中异喹胍和非那西丁的代谢
J Pharm Pharmacol. 1981 Mar;33(3):161-4. doi: 10.1111/j.2042-7158.1981.tb13740.x.
8
Relationship of N-demethylation of amiflamine and its metabolite to debrisoquine hydroxylation polymorphism.
Clin Pharmacol Ther. 1984 Oct;36(4):515-9. doi: 10.1038/clpt.1984.212.
9
Metoprolol metabolism and debrisoquine oxidation polymorphism--population and family studies.美托洛尔代谢与异喹胍氧化多态性——群体与家系研究
Br J Clin Pharmacol. 1985 Dec;20(6):555-66. doi: 10.1111/j.1365-2125.1985.tb05112.x.
10
Relationship between oxidative metabolism of 2-acetylaminofluorene, debrisoquine, bufuralol, and aldrin in human liver microsomes.人肝微粒体中2-乙酰氨基芴、异喹胍、丁呋洛尔和艾氏剂的氧化代谢之间的关系。
Cancer Res. 1984 Dec;44(12 Pt 1):5692-7.

引用本文的文献

1
Debrisoquine hydroxylation in a Polish population.
Eur J Clin Pharmacol. 1995;47(6):503-5. doi: 10.1007/BF00193702.
2
Debrisoquine oxidation polymorphism in a Tasmanian population.塔斯马尼亚人群中的异喹胍氧化多态性。
Eur J Clin Pharmacol. 1991;40(5):529-32. doi: 10.1007/BF00315235.